Cat: IPD-X41549

Recombinant Oenococcus oeni mleA Protein ,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    mleA

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    (MLE)

  • Species

    Oenococcus oeni

  • Source

    E. coli

  • Tag

    N- His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q48796

  • Expression Region

    260-516aa

  • Molecular Weight

    31.2 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

The study of MleA recombinant protein has garnered significant interest due to its potential role in various biological processes and applications in biotechnology. MleA, originally identified in certain bacterial species, is believed to be involved in the regulation of gene expression and metabolic pathways. Its unique structural features suggest that it may interact with various biomolecules, influencing cellular functions. Research has shown that MleA exhibits potential as a target for antibiotic development, especially against drug-resistant strains, due to its critical role in bacterial survival. Additionally, MleA's ability to form complexes with other proteins opens avenues for its application in synthetic biology, where it could be engineered for enhanced functionalities. Scientists are also investigating the recombinant expression of MleA to explore its biochemical properties and functional mechanisms in vitro, which could provide insights into its role in pathogenesis and cellular metabolism. Thus, understanding the dynamics of MleA can pave the way for novel therapeutic strategies and biotechnological innovations, making it a focal point of current research in microbiology and molecular biology.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US